HYDROCORTISONE SODIUM SUCCINATE ( DrugBank: Hydrocortisone )

3 diseases

81. 先天性副腎皮質酵素欠損症

臨床試験数 : 87 / 薬物数 : 87 - (DrugBank : 23) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 68

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-005822-23-SE (EUCTR)	18/11/2014	20/09/2013	A trial comparing continuous subcutaneous hydrocortisone infusion (CSHI) therapy with conventional o ...	CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA	Congenital Adrenal Hyperplasia MedDRA version: 14.1;Level: LLT;Classification code 10010323;Term: Co ...	Trade Name: Solu-Cortef INN or Proposed INN: HYDROCORTISONE SODIUM SUCCINATE Other descriptive name: H ...	Haukeland University Hospital	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Norway;Sweden

臨床試験数 : 20 / 薬物数 : 39 - (DrugBank : 13) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 18

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-010917-61-SE (EUCTR)	25/08/2010	05/07/2010	Glucocorticoid Replacement in Addison's disease	Glucocorticoid Replacement in Addison's disease	Autoimmune Addison's disease is a rare and chronic disease wich leads to primary adrenal failure. Th ...	Trade Name: Solu-Cortef INN or Proposed INN: HYDROCORTISONE SODIUM SUCCINATE Product Name: Hydrokortis ...	Haukeland University hospital	NULL	Not Recruiting			Female: yes Male: yes	40		Sweden

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03110198 (ClinicalTrials.gov)	May 2017	19/2/2017	Mesalazine With Hydrocortisone Sodium SuccinateEnema for 4-Week Treatment in Patients With Ulcerativ ...	A Randomized, Double-blind Study Investigating the Efficacy and Safety of Mesalazine With Hydrocorti ...	Ulcerative Colitis, Unspecified	Drug: Mesalazine;Drug: hydrocortisone sodium succinate;Drug: Mesalazine with hydrocortisone sodium s ...	Xijing Hospital of Digestive Diseases	Shanghai Tongji Hospital, Tongji University School of Medicine;First Affiliated Hospital of Zhongsha ...	Recruiting	18 Years	70 Years	All	528	Phase 4	China